BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2016 10:17:00 AM | Browse: 1222 | Download: 1787
 |
Received |
|
2016-02-02 10:19 |
 |
Peer-Review Started |
|
|
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
|
 |
Revised |
|
|
 |
Second Decision |
|
2016-02-17 09:11 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2016-03-09 12:55 |
 |
Articles in Press |
|
2016-03-09 12:56 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-04-05 15:32 |
 |
Publish the Manuscript Online |
|
2016-04-11 10:17 |
ISSN |
2220-6132 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cell Biology |
Manuscript Type |
Review |
Article Title |
Gene editing for corneal disease management
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sudhanshu P Raikwar, Apoorva S Raikwar, Shyam S Chaurasia and Rajiv R Mohan |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Veteran Health Affairs Merit grant |
1I01BX000357-05 (to Mohan RR) |
National Eye Institute, NIH grant |
R01EY017294 (to Mohan RR) |
Ruth M. Kraeuchi Missouri Endowment of Ophthalmology |
(to Mohan RR) |
|
Corresponding Author |
Rajiv R Mohan, PhD, FARVO, Professor, Ophthalmology and Molecular Medicine, One-health One-Medicine Ophthalmology and Vision Research, University of Missouri, 1600 E. Rollins Road, Columbia, MO 65211,
United States. mohanr@health.missouri.edu
|
Key Words |
Adeno-associated virus; Clustered Regularly-Interspaced Short Palindromic Repeats associated protein 9; Cornea; Clustered Regularly Interspaced Short Palindromic Repeat; Double strand breaks; Gene editing; sgRNA; Gene targeting; Homology directed repair; Homologous recombination; Indels; Lentiviral vector; Protospacer-adjacent motif; Transcription activator like effector nucleases; Zinc finger nucleases |
Core Tip |
Gene editing technology including clustered regularly interspaced short palindromic repeats/Clustered Regularly Interspaced Short Palindromic Repeats
associated protein 9, zinc finger nucleases, or transcription activator like effector nucleases has great potential for generating in vitro and in vivo models of corneal diseases including keratoconus and Fuchs’ endothelial corneal dystrophy. Furthermore, gene editing is a powerful tool for studying molecular mechanisms mediating corneal development, pathogenesis and developing next generation innovative gene therapies including the patient-specific personalized medicine for curing corneal diseases. This review discusses current status and latest developments in the field of gene editing. Gene editing based molecular therapy has the potential to revolutionize current pra-ctices in ophthalmology clinic for curing corneal blind-ness.
|
Publish Date |
2016-04-11 10:17 |
Citation |
Raikwar SP, Raikwar AS, Chaurasia SS, Mohan RR. Gene editing for corneal disease management. World J Transl Med 2016; 5(1): 1-13 |
URL |
http://www.wjgnet.com/2220-6132/full/v5/i1/1.htm |
DOI |
http://dx.doi.org/10.5528/wjtm.v5.i1.1 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345